Biomarkers /

DAB2IP

Back to Biomarkers List
Associated Diseases

Overview

Location [1]
9q33.2
Protein [2]
Disabled homolog 2-interacting protein
Synonyms [1]
DIP1/2, AIP1, AF9Q34, AIP-1

DAB2IP is altered in 0.04% of all cancers with anal squamous cell carcinoma, cancer of unknown primary, NOS, invasive breast carcinoma, lung adenocarcinoma, and poorly differentiated non-small cell lung cancer having the greatest prevalence of alterations [3].

DAB2IP GENIE Cases - Top Diseases

The most common alteration in DAB2IP is DAB2IP-NTRK2 Fusion (0.04%) [3].

DAB2IP GENIE Cases - Top Alterations

References

1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20180821. San Francisco CA: Github;2015. https://github.com/biocommons/uta

2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.

3. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

4. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.